Oxford-AstraZeneca researchers attempt to battle variants
Published
Researchers at Oxford-AstraZeneca are working on a more effective shot to tackle new coronavirus variants. The testing comes as the company conducts U.S. trials to present for FDA approval. CBS News foreign correspondent Charlie D'Agata reports.
Full Article